Alabama collaborating physician requirements apply to one of the most tightly regulated restricted-practice markets in the country. Alabama has no pathway to independent APRN practice. Every Certified Registered Nurse Practitioner and Certified Nurse-Midwife who practices medicine in Alabama must do so under a collaborative agreement jointly approved by the Alabama Board of Medical Examiners and the Alabama Board of Nursing. That joint approval structure, the experience-based on-site presence obligations, the FTE-based ratio cap that includes out-of-state arrangements, and the specific controlled substance prescribing framework through the Qualified Alabama Controlled Substances Certificate make Alabama one of the most compliance-intensive states for collaborating physicians.
For physicians entering collaboration roles in Alabama, every element of this framework requires active attention throughout the collaboration, not just at signing. This guide covers every requirement a physician needs to understand in 2026, sourced directly from Alabama statutes, ABME administrative rules, and current board guidance.
Alabama Collaborating Physician Overview: Where Alabama Stands
Alabama classifies CRNPs and CNMs in the restricted-practice category with no independence pathway and no experience threshold that changes the collaboration obligation. The requirement is career-long and absolute.
Governing Bodies
Two regulatory bodies jointly govern collaborative practice in Alabama:
- Alabama Board of Medical Examiners (ABME): Governs physician licensure, physician collaborative practice applications, the QACSC and Limited Purpose Schedule II Permit framework, controlled substance prescribing requirements, the CE obligation for collaborating physicians, and disciplinary oversight under Chapter 540-X-8 of the Alabama Administrative Code.
- Alabama Board of Nursing (ABN): Governs CRNP and CNM licensure, collaborative agreement applications from the APRN side, prescriptive authority certificates, and disciplinary oversight under Chapter 610-X-5 of the Alabama Administrative Code.
Both boards must jointly approve an initial collaborative practice before the CRNP may begin practicing or prescribing. A temporary approval from the ABN is not issued until the ABN is notified by the ABME that the commencement application has been processed.
The January 2025 CE Requirement
Effective January 1, 2025, the ABME implemented a new continuing medical education requirement for all physicians entering new collaborative practice arrangements. For any new collaborative practice commenced after January 1, 2025, the collaborating physician must complete ABME-approved CME related to collaborative practice. Physicians who completed the required course within 60 months prior to January 1, 2025 may count that toward the requirement. Physicians beginning new collaborations have 12 months from commencement to obtain the required CME. The ABME provides free on-demand online courses to meet this requirement.
The Collaborative Agreement: Alabama’s Core Compliance Document
Alabama uses the term collaborative agreement as the foundational legal document governing the CRNP’s practice under the physician’s collaboration. The collaborative agreement must be jointly approved by both the ABME and the ABN before the CRNP may begin practicing. The agreement specifies the approved duties, skills, and prescribing privileges of the CRNP and sets forth the quality assurance plan that governs the ongoing oversight obligations.
Where the Agreement Lives
The collaborating physician must maintain an updated copy of the quality assurance plan for each CRNP on file with the ABME. A copy of the collaborative agreement must also be retained by both parties and be available for inspection.
When the Agreement Continues and When It Ends
Once approved, the collaborative agreement continues in effect until notification of termination is received by both boards. There is no automatic expiration date. The agreement does not expire on a fixed cycle the way it does in states like Georgia or Tennessee. Both the physician and the CRNP must affirmatively notify their respective boards when the arrangement ends.
The Dual-Board Approval Process: ABME and ABN
Alabama’s dual-board approval process is one of the most consequential compliance prerequisites in any state in this series. Neither the ABME approval alone nor the ABN approval alone is sufficient to authorize the CRNP to begin practicing.
The Physician’s Application Process
The collaborating physician applies for approval of an initial collaborative practice through the Licensee Gateway on the ABME website. The physician must review the instructions and rules regarding collaborative practices during the application process. The application requires documentation of the collaborative agreement and related materials.
The CRNP’s Application Process
The CRNP applies to the Alabama Board of Nursing for approval of an initial or modified collaborative agreement through the ABN’s online system. A temporary approval for collaborative practice will not be issued until the ABN is notified by the ABME that the commencement application has been processed.
Joint Approval Sequence
The practical effect of the dual-board structure is that both applications must be submitted and both boards must complete their reviews before the CRNP is authorized to begin. The CRNP’s temporary approval from the ABN is contingent on the ABME having processed the physician’s commencement application. Physicians who delay submitting their ABME application hold up the entire process.
What Must Be in an Alabama Collaborative Agreement
Alabama Administrative Code Chapter 540-X-8 and Chapter 610-X-5 specify the required content of a valid collaborative agreement. The agreement must address all of the following:
1. Approved Duties and Skills
The agreement must specify the duties the CRNP is authorized to perform. Any duties or skills not included in the core skills list approved by the boards must be requested separately. The scope of approved duties is specific to each arrangement and must be listed in the agreement.
2. Prescribing Privileges
The legend and controlled drugs a CRNP is authorized to prescribe must be specified in the collaborative agreement and associated formularies. General statements about prescribing authority are insufficient. The specific drug categories and schedules authorized for the CRNP must be named.
3. Quality Assurance Plan
The agreement must include a written plan for quality assurance management with defined quality outcome measures for evaluation of the CRNP’s clinical practice. The plan must include a review of a meaningful sample of medical records plus all adverse outcomes. The physician must complete quarterly quality assurance reviews with each CRNP and maintain documentation of those reviews for the duration of the collaboration and for three years after termination.
4. Hours and Supervision Structure
The agreement must reflect the physician’s on-site presence obligations based on the CRNP’s level of experience. For CRNPs with less than 4,000 hours of collaborative practice experience, this includes the 10% on-site presence requirement. For experienced CRNPs, the quarterly meeting and biannual site visit obligations must be addressed.
5. Covering Physician Designation
If a covering physician will be named to provide collaboration when the primary physician is unavailable, that covering physician must be identified in the agreement. The covering physician must be pre-approved and must meet all conditions required of the primary collaborating physician.
Physician Eligibility: The New CE Requirement and the QACSC Standard
Active License and QACSC Requirement
A qualifying Alabama collaborating physician must hold an active, current, and unrestricted Alabama medical license. For collaborative arrangements where the CRNP will prescribe controlled substances, the collaborating physician must themselves hold a valid, current, and unrestricted Qualified Alabama Controlled Substances Certificate. Under Alabama Administrative Code § 540-X-18-.03, a CRNP may only apply for a QACSC when practicing in a collaborative arrangement with a physician who holds and maintains a valid QACSC. A physician without a current QACSC cannot serve as the collaborating physician for a CRNP who wishes to prescribe controlled substances.
The CE Requirement for Collaborating Physicians
For all new collaborative practices commenced after January 1, 2025, the collaborating physician must complete ABME-approved continuing medical education related to collaborative practice. Physicians who have taken the course within 60 months prior to January 1, 2025 may apply that toward the requirement. Physicians beginning new arrangements after January 1, 2025 have 12 months from the commencement date to complete the required education. The ABME provides free on-demand online courses to meet this obligation directly on the ABME website.
The 10% On-Site Presence Obligation for Early-Career CRNPs
One of Alabama’s most operationally distinctive requirements applies to collaborative arrangements with CRNPs who have less than 4,000 hours of collaborative practice experience. Under Ala. Admin. Code r. 610-X-5-.09, the collaborating physician must be present for not less than 10% of the CRNP’s scheduled hours at the approved practice site during this early-career period.
What Counts Toward the 10% Requirement
The physician’s presence when working in the same facility as the CRNP counts toward this requirement. The physician’s presence in the facility, even if not directly supervising at every moment, satisfies the standard when the physician is in the same building as the CRNP.
What Is Exempt
The CRNP’s scheduled hours in patient homes, facilities licensed by the Alabama Department of Public Health, facilities certified by the Alabama Department of Mental Health, and when practicing under specified limited protocols are not subject to the required minimum hours for physician presence. These exempt categories reduce the practical burden of the 10% requirement for CRNPs working in home health, public health, or mental health settings.
Documentation of the 10% Presence
The physician must maintain documentation of the CRNP’s two-year (4,000-hour) collaborative practice experience for the duration of the collaborative practice and for three years following termination. This documentation serves as the record that supports transition from the early-career 10% requirement to the less intensive oversight structure available after 4,000 hours.
Ongoing Oversight After 4,000 Hours: Site Visits and Quarterly Meetings
Once a CRNP has completed two years or 4,000 hours of collaborative practice experience, the physician’s on-site presence obligation changes significantly. The 10% presence requirement no longer applies, and the oversight framework shifts to a less intensive structure.
Remote Site Visits
For CRNPs with 4,000 hours or more of experience, the collaborating physician must visit remote practice sites at least twice annually. These visits must be documented.
Quarterly Quality Assurance Meetings
The collaborating physician must meet with the CRNP for quality assurance purposes no less than quarterly, regardless of the CRNP’s experience level. For experienced CRNPs, these quarterly meetings are the primary structured oversight mechanism beyond remote site visits. Each quarterly meeting must be documented, and that documentation must be maintained for the duration of the collaboration and for three years after termination.
The Covering Physician Designation
Alabama specifically permits the designation of a covering physician who can provide collaboration with the CRNP when the primary collaborating physician is unavailable. The covering physician must be named and pre-approved through the agreement process.
Requirements for Covering Physicians
The covering physician must be pre-approved by the boards and must meet all conditions required of the primary collaborating physician. For controlled substance arrangements, a covering physician who will authorize controlled substance prescribing must also hold a valid QACSC.
Why This Matters
The covering physician provision is important for managing the Alabama requirement that controlled substance verbal orders written by the CRNP must be approved by the collaborating, supervising, or covering physician and the physician’s signature must be obtained within seven days of the verbal order. Without a named covering physician, the primary physician must be continuously available to fulfill this function.
The FTE Ratio: 360 Hours Per Week Including Out-of-State Arrangements
Alabama imposes a specific and distinctive ratio cap for collaborating physicians that is calculated in FTE hours rather than a simple head count, and which applies across all states where the physician holds collaborative arrangements.
The 360-Hour Weekly Cap
Under Alabama Administrative Code Chapter 610-X-5, a physician may enter into collaborative agreements with CRNPs not exceeding a cumulative 360 hours per week (nine FTEs). The physician shall not collaborate with or supervise any combination of CRNPs, CNMs, and PAs exceeding 360 hours per week (nine full-time equivalent positions), inclusive of collaborative and supervisory agreements existing in other states.
One full-time equivalent is defined as a person or persons collectively working 40 hours per week. A CRNP working 40 hours per week counts as one FTE toward the cap.
The Cross-State Disclosure Obligation
The physician must disclose to the ABME the existence of all collaborative and supervisory agreements to which the physician is a party, including agreements in other states. This disclosure obligation ensures the ABME can verify that the physician is not exceeding the 360-hour total across all jurisdictions.
This cross-state cap is one of the most unusual and consequential features of Alabama’s framework. A physician who collaborates with CRNPs in Alabama and in other states must count all active FTEs across every state toward the 360-hour limit. A physician at seven Alabama FTEs cannot enter a two-FTE arrangement in another state without exceeding the cap.
Prescriptive Authority: QACSC and the Limited Purpose Schedule II Permit
Alabama’s controlled substance prescribing framework for CRNPs operates through two separate board-issued certificates. Both require the CRNP to be in a qualifying collaborative arrangement with a physician who holds a valid QACSC.
The Qualified Alabama Controlled Substances Certificate
Under Alabama Administrative Code § 540-X-18-.03, a CRNP may apply for a QACSC when they:
- Are practicing in compliance with all ABME and ABN collaborative practice rules
- Are in a collaborative practice with a physician who holds a valid, current, and unrestricted QACSC
- Have submitted proof of successful completion of a board-approved course that includes 8 hours of instruction on prescribing controlled substances and 4 hours of advanced pharmacology and prescribing trends within one year preceding the application
- Hold a valid DEA registration
The QACSC is renewed annually on or before January 1 of each year. Late renewals received in January incur a $75 late fee in addition to the $60 renewal fee.
The Limited Purpose Schedule II Permit
To prescribe Schedule II controlled substances, a CRNP must also apply for and receive a Limited Purpose Schedule II Permit from the ABME. The LPSP is separate from and additional to the QACSC. A CRNP may not prescribe Schedule II controlled substances under any circumstances without both a QACSC and an LPSP.
Controlled Substance Prescribing Rules and the Annual Patient Evaluation
Alabama’s controlled substance prescribing framework for CRNPs involves specific requirements for first prescriptions, ongoing treatment, and the escalation of Schedule II prescriptions.
First Prescription Requirement
The initial prescription for a controlled substance for a patient must be issued by the collaborating physician. After the physician has evaluated the patient and approved the medication, the CRNP holding a QACSC may issue subsequent prescriptions.
Verbal Orders and the Seven-Day Signature Requirement
A CRNP may call or write a verbal order for a controlled substance provided the collaborating, supervising, or covering physician has approved the medication and either signed the prescription or given a verbal order recorded in the medical record. The physician must sign that verbal order within seven days.
The Annual In-Person Patient Evaluation
Under ABME rules, the collaborating physician must conduct an in-person evaluation of any patient receiving ongoing treatment with controlled substances at least once every 12 months. At the time of that evaluation, any controlled substance prescriptions must be reissued or refilled exclusively by the physician using the physician’s own Alabama Controlled Substances Certificate and DEA registration.
This annual patient evaluation obligation is one of the most clinically intensive ongoing requirements for Alabama collaborating physicians. Physicians who collaborate with CRNPs in practices with significant controlled substance patient panels must plan for the time these annual evaluations require.
Schedule II Escalation Rules
Any escalation of a previously prescribed Schedule II or IIN controlled substance must occur through collaboration with the approved collaborating, supervising, or covering physician and must be documented in the medical record. A CRNP cannot independently escalate a Schedule II dose.
Termination Notification Obligations
When a collaborative practice ends, both the physician and the CRNP must notify their respective boards.
The Physician’s Obligation
The collaborating physician must notify the Alabama Board of Medical Examiners of the commencement or termination of collaborative practice as required by Rule 540-X-8-.04. This notification must be given to the ABME, and the physician cannot backdate the termination notification.
The CRNP’s Obligation
The CRNP must submit a Terminate an Existing Collaboration application to the ABN, indicating the final date of practice with the physician listed in the online profile. Termination applications from the ABN side cannot be backdated.
Adding a New Collaboration
To add a new collaboration after terminating an existing one, the CRNP must submit an Add New Collaboration application through the ABN’s online system. The process resets through the dual-board approval structure.
Common Compliance Mistakes Alabama Collaborating Physicians Make
Alabama’s compliance requirements are specific enough that documentation failures are common even among physicians who understand their general obligations.
- CE requirement not completed within 12 months of commencement. For new collaborations commenced after January 1, 2025, the collaborating physician has 12 months from commencement to complete the required ABME-approved CME. Missing this window creates a compliance gap on the physician’s ABME record.
- QACSC not current when CRNP applies for controlled substance authority. The CRNP cannot obtain a QACSC unless the collaborating physician holds a valid, current, and unrestricted QACSC. A physician with a lapsed or restricted QACSC cannot support a CRNP’s controlled substance application regardless of other credentials.
- 10% on-site presence not documented for early-career CRNPs. For CRNPs with under 4,000 hours of experience, the physician must be present for 10% of the CRNP’s scheduled hours and must maintain documentation of the CRNP’s hours toward the 4,000-hour threshold for three years after termination.
- Quarterly quality assurance meetings not held or not documented. Quarterly QA meetings are required for all CRNPs regardless of experience level. Documentation of each meeting must be maintained and available for board inspection.
- Cross-state FTE cap exceeded. The 360-hour weekly cap applies across all states. A physician who does not disclose out-of-state arrangements to the ABME may be in violation of the cap without knowing it.
- Annual in-person patient evaluation not conducted for controlled substance patients. Every patient receiving ongoing controlled substance treatment must be evaluated in person by the collaborating physician at least once every 12 months. Missing this obligation is a compliance failure even when the CRNP has been managing the patient competently.
- Covering physician not pre-approved. If the primary physician named in the agreement is unavailable, the covering physician designated to provide collaboration must be pre-approved by the boards. An informal backup arrangement without board approval does not satisfy the requirement.
Alabama Collaborating Physician Requirements: Quick Reference
Physician Eligibility
- Active, current, unrestricted Alabama medical license
- Must hold a valid QACSC if the CRNP will prescribe controlled substances
- Must complete ABME-approved CME for new collaborations commenced after January 1, 2025; 12 months from commencement to complete
- Must disclose all collaborative arrangements including out-of-state agreements to ABME
Core Compliance Document
- Written collaborative agreement meeting requirements of Ala. Admin. Code Ch. 540-X-8 and 610-X-5
- Jointly approved by ABME and ABN before CRNP may begin practicing
- Must address: approved duties, prescribing privileges, quality assurance plan, oversight structure based on CRNP experience level, covering physician designation
Dual-Board Approval
- Physician applies through ABME Licensee Gateway
- CRNP applies through ABN online system
- ABN temporary approval not issued until ABME commencement application processed
On-Site Presence Obligations
- CRNPs under 4,000 hours: physician must be present for not less than 10% of CRNP’s scheduled hours at the practice site
- CRNPs with 4,000+ hours: physician visits remote sites at least twice annually; meets quarterly
- Quarterly quality assurance meetings required for all CRNPs
FTE Ratio
- Maximum 360 hours per week (9 FTEs) combined across all collaborative and supervisory arrangements in all states
Controlled Substance Framework
- QACSC required for controlled substance prescribing; collaborating physician must hold a valid QACSC
- Limited Purpose Schedule II Permit required for Schedule II prescribing
- First prescription for any controlled substance must be issued by the physician
- In-person physician evaluation of controlled substance patients required at least once every 12 months
- Verbal orders must be signed by physician within 7 days
Termination
- Physician notifies ABME of commencement or termination
- CRNP submits Terminate an Existing Collaboration application to ABN
- Neither application can be backdated
Clinics Also Need to Understand Alabama Collaboration Requirements
While this guide primarily covers the responsibilities and compliance requirements placed on collaborating physicians in Alabama, these regulations directly affect CRNP-owned clinics, medspas, and healthcare practices that depend on physician collaboration to operate. In many cases, clinic owners researching Alabama collaboration rules are also trying to understand how to find a qualified physician who holds a valid QACSC for controlled substance coverage, has capacity within the 360-hour cross-state FTE cap, and can fulfill the 10% on-site presence requirement if the CRNP has under 4,000 hours of experience.
Need Help Finding an Alabama Collaborating Physician?
For clinics, understanding the legal requirements is only one part of the process. The next challenge is finding a qualified physician who meets the QACSC requirement for controlled substance coverage, is prepared to complete the new CME obligation for arrangements commenced after January 1, 2025, and can fulfill both the early-career on-site presence obligations and the quarterly QA meeting standard throughout the collaboration. Whether you are launching a new clinic, replacing a physician whose collaborative agreement has been terminated, or managing the controlled substance annual patient evaluation requirement, having the right physician in place from the start matters.
If your clinic is actively looking for an Alabama collaborating physician, our team can match you with a qualified physician, often within 24 to 48 hours. We work with clinics across Alabama to simplify the physician matching process while supporting collaborative agreement drafting, dual-board application submissions, QACSC verification, and long-term collaboration needs.
Final Thoughts
Alabama collaborating physician requirements are among the most operationally specific in the country. The dual-board approval structure, the experience-based on-site presence obligations, the cross-state FTE cap, the controlled substance framework built around the QACSC and LPSP, the annual in-person patient evaluation requirement, and the January 2025 CE mandate for new collaborations all demand active, documented attention throughout the life of the arrangement.
For physicians entering the Alabama market, the most important steps are ensuring QACSC status is current before any CRNP applies for controlled substance authority, completing the new CME obligation within 12 months of commencing a new arrangement, maintaining thorough documentation of quarterly QA meetings and on-site presence, and tracking total FTE commitments across all states to stay within the 360-hour cap.
Build a Compliant Alabama Collaboration With Collaborating Physician
Are you looking for a collaborating physician role in Alabama? If you are a licensed Alabama physician interested in a structured, compliant collaboration arrangement with a CRNP-operated clinic, Collaborating Physician handles the infrastructure so you do not have to navigate it alone. The platform connects licensed physicians with vetted clinics across Alabama and 50-plus other states. Every arrangement is built to meet state-specific requirements, including Alabama’s dual-board approval process under ABME and ABN rules, the January 2025 CME requirement, the QACSC and LPSP framework, experience-based on-site presence obligations, quarterly QA meeting standards, the annual controlled substance patient evaluation requirement, and the cross-state FTE ratio. Physicians receive compliance support throughout the collaboration, not just at the start. Applications take under ten minutes. Clinic matches typically happen within 24 to 48 hours. There is no cost to physicians at any stage.
If you are a clinic owner who found this page, we have something for you as well. Collaborating Physician also matches Alabama clinics with qualified, vetted collaborating physicians who hold current QACSCs, have completed the new 2025 CME requirement, and are prepared to fulfill the experience-appropriate on-site obligations and quarterly QA meetings that Alabama specifically requires. Whether you are launching a new clinic, replacing a physician whose collaborative agreement has been terminated, or managing a new CRNP approaching the 4,000-hour transition from intensive to standard oversight, the network is active and placements happen within 24 to 48 hours. For clinics looking for a collaborating physician, get matched fast.
Disclaimer: This content is for educational and informational purposes only. It does not constitute legal or medical advice. Alabama healthcare regulations change frequently. Always verify current requirements directly with the Alabama Board of Medical Examiners, the Alabama Board of Nursing, and a qualified healthcare attorney before making any practice decisions.
Frequently Asked Questions
Does an Alabama collaborating physician need to be physically present at the CRNP’s clinic?
Yes, under certain conditions. For CRNPs with fewer than 4,000 hours of collaborative practice experience, the physician must be present at the practice site for not less than 10% of the CRNP’s scheduled hours. For CRNPs with 4,000 or more hours of experience, the physician must visit remote practice sites at least twice annually. When working in the same facility as the CRNP, no additional documentation of on-site presence is required.
What is the QACSC and why does it matter for collaborating physicians?
The Qualified Alabama Controlled Substances Certificate is the state-issued authorization that allows a CRNP or CNM to prescribe controlled substances. A CRNP can only apply for a QACSC if their collaborating physician holds a valid, current, and unrestricted QACSC. If the physician’s QACSC lapses or is restricted, the CRNP loses the ability to prescribe controlled substances under the arrangement.
What is the Limited Purpose Schedule II Permit?
The Limited Purpose Schedule II Permit is a separate authorization required for CRNPs to prescribe Schedule II controlled substances. It is in addition to the QACSC. A CRNP who holds a QACSC but not an LPSP may not prescribe Schedule II controlled substances under any circumstances.
What is Alabama’s FTE cap for collaborating physicians?
A physician may not collaborate with or supervise any combination of CRNPs, CNMs, and PAs exceeding 360 hours per week, which equals nine full-time equivalent providers at 40 hours per week each. This cap applies across all collaborative and supervisory agreements in all states. Physicians with out-of-state arrangements must disclose those to the ABME and count them toward the 360-hour limit.
What is the new CE requirement for Alabama collaborating physicians?
For all new collaborative practices commenced after January 1, 2025, the collaborating physician must complete ABME-approved continuing medical education related to collaborative practice. Physicians have 12 months from the commencement date to complete the required CME. The ABME provides free on-demand online courses to meet this requirement.
Does an Alabama physician need to see controlled substance patients in person?
Yes. The collaborating physician must conduct an in-person evaluation of any patient receiving ongoing treatment with controlled substances at least once every 12 months. At the time of that evaluation, any controlled substance prescriptions must be reissued or refilled exclusively by the physician using the physician’s own Alabama Controlled Substances Certificate and DEA registration.
